Chemoinformaics analysis of Epicatechin-3-O-gallate
| Molecular Weight | 442.376 | nRot | 3 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 24 |
| Exact Molecular Weight | 442.09 | nRing | 4 |
| Solubility: LogS | -4.013 | nHRing | 1 |
| Solubility: LogP | 2.374 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 3 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 18 |
| nHA | 10 | APOL | 56.7623 |
| nHD | 7 | BPOL | 22.3977 |
| QED | 0.235 |
| Synth | 3.608 |
| Natural Product Likeliness | 1.842 |
| NR-PPAR-gamma | 0.155 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.001 |
| HIA | 0.618 |
| CACO-2 | -6.538 |
| MDCK | 0.00000512 |
| BBB | 0.008 |
| PPB | 0.917338 |
| VDSS | 0.466 |
| FU | 0.0523191 |
| CYP1A2-inh | 0.463 |
| CYP1A2-sub | 0.082 |
| CYP2c19-inh | 0.06 |
| CYP2c19-sub | 0.037 |
| CYP2c9-inh | 0.631 |
| CYP2c9-sub | 0.403 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.205 |
| CYP3a4-inh | 0.14 |
| CYP3a4-sub | 0.101 |
| CL | 15.966 |
| T12 | 0.93 |
| hERG | 0.069 |
| Ames | 0.419 |
| ROA | 0.102 |
| SkinSen | 0.96 |
| Carcinogencity | 0.071 |
| EI | 0.935 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.379 |
| Antiviral | Yes |
| Prediction | 0.881416 |